CHRS
Coherus BioSciences Inc
1.00$
-8.0%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | 15.7 | 8.3 | 8.8 | 9.9 | 11.5 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 5.7 | – | – | – | – | – | – | |
| 6.9 | 6.6 | 5.8 | 4.5 | 190.9 | 113.9 | 153.6 | 303.4 | 719.5 | – | 25.3 | 13.4 | 6.9 | 4.0 | 2.8 | 3.3 | 3.3 | 3.2 | 2.4 | 2.6 | 3.5 | 3.8 | 3.3 | 2.0 | 3.1 | 2.9 | 2.9 | 2.1 | 1.7 | 1.4 | 1.3 | 0.8 | 0.5 | 0.8 | 0.5 | 0.6 | 2.2 | 4.0 | 4.9 | 4.3 | |
| 42.1 | 64.6 | 13.2 | 23.0 | 12.9 | 16.8 | – | 14.2 | 90.3 | – | – | – | 28.5 | 13.4 | 7.7 | 7.4 | 6.3 | 5.4 | 8.3 | 6.7 | 9.7 | 12.6 | 79.3 | – | – | – | – | – | – | – | – | – | – | – | – | 0.7 | 2.1 | 2.8 | 2.9 | 3.6 | |
| 6.5 | 6.3 | 5.5 | 4.6 | 201.9 | 102.7 | 152.3 | 320.1 | 703.9 | – | 28.0 | 14.0 | 6.9 | 4.0 | 2.7 | 3.6 | 3.5 | 2.9 | 2.7 | 2.8 | 3.6 | 3.7 | 3.0 | 1.9 | 2.9 | 3.7 | 4.1 | 2.9 | 3.6 | 2.9 | 2.3 | 1.3 | 1.2 | 1.6 | 1.4 | -0.7 | 1.5 | 2.8 | 3.3 | 3.4 | |
| – | – | – | – | – | – | – | – | – | – | – | – | 239.5 | 12.5 | 7.0 | 8.5 | 9.0 | 8.5 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 53.2 | 12.6 | 11.3 | 12.1 | 10.4 | 7.8 | 13.4 | 27.5 | – | – | – | – | – | – | – | – | – | – | – | – | – | 187.7 | – | – | – | – | – | |
| -11.9% | -20.7% | -24.7% | -38.5% | -36.6% | -39.9% | -24.5% | -15.9% | -12.7% | -25.8% | -19.5% | -8.4% | -2.4% | 1.9% | 7.9% | 8.9% | 8.3% | 9.6% | 12.8% | 7.5% | 3.6% | -3.1% | -9.5% | -26.0% | -26.2% | -39.5% | -47.8% | -65.4% | -72.5% | -47.6% | -50.8% | -27.8% | -53.8% | -12.6% | 0.5% | -124.9% | -48.5% | -82.2% | -73.6% | -112.5% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| -23.6% | -33.8% | -36.5% | -27.4% | -4,906.7% | -3,527.3% | -3,010.0% | -4,253.8% | -7,110.9% | – | -124.1% | 52.5% | 84.5% | 95.2% | 95.0% | 93.6% | 93.1% | 92.1% | 91.3% | 88.6% | 84.3% | 82.4% | 80.4% | 80.4% | 71.6% | 66.8% | 57.7% | 49.9% | 58.0% | 38.2% | 36.8% | 36.5% | 40.6% | 55.5% | 55.5% | 56.1% | 44.2% | 57.9% | 60.0% | 63.6% | |
| -47.5% | -61.0% | -69.7% | -71.4% | -6,828.2% | -5,150.6% | -4,642.2% | -6,439.3% | -12,235.2% | – | -482.5% | -88.4% | 1.0% | 30.3% | 38.0% | 41.7% | 37.8% | 32.9% | -11.7% | -35.8% | -57.2% | -80.8% | -58.4% | -71.4% | -102.5% | -121.7% | -132.9% | -128.7% | -88.0% | -79.0% | -89.5% | -81.1% | -71.3% | -71.2% | -58.0% | -97.7% | -209.9% | -424.5% | -362.1% | -307.4% | |
| -52.0% | -67.0% | -76.9% | -73.9% | -6,983.5% | -5,284.4% | -4,778.9% | -6,641.5% | -12,584.2% | – | -498.8% | -97.8% | -5.2% | 25.2% | 33.4% | 37.1% | 33.1% | 27.8% | -17.2% | -41.9% | -63.7% | -87.9% | -69.2% | -83.5% | -116.5% | -138.2% | -148.0% | -145.2% | -102.9% | -92.5% | -26.1% | -12.6% | -0.2% | 14.8% | -66.3% | -111.6% | -219.8% | -403.8% | -323.5% | -257.1% | |
| -82.5% | -136.3% | -143.6% | -172.1% | -6,990.4% | -4,545.4% | -3,763.4% | -4,830.8% | -9,158.7% | – | -495.2% | -112.6% | -16.5% | 7.5% | 22.0% | 28.9% | 27.0% | 30.9% | 30.8% | 19.8% | 12.7% | -11.9% | -31.2% | -52.5% | -82.0% | -115.2% | -140.4% | -134.9% | -124.2% | -68.1% | -67.4% | -23.3% | -27.0% | -10.6% | 0.3% | -74.2% | -107.9% | -328.4% | -363.8% | -478.9% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -315.8% | -657.9% | -174.9% | -379.9% | -471.6% | -780.0% | – | -310.2% | -1,579.9% | – | – | – | -21.4% | 85.4% | 92.5% | 84.8% | 63.3% | 47.1% | -59.7% | -105.8% | -177.2% | -293.8% | -1,673.5% | – | – | – | – | – | – | – | – | – | – | – | – | -133.0% | -209.3% | -279.1% | -192.9% | -215.3% | |
| -54.0% | -71.3% | -60.1% | -70.9% | -139.7% | -146.5% | -161.7% | -104.1% | -138.4% | -210.5% | -99.4% | -49.0% | -3.7% | 22.0% | 31.2% | 23.9% | 20.1% | 15.7% | -11.0% | -22.3% | -31.2% | -42.3% | -35.4% | -42.2% | -50.6% | -60.7% | -67.4% | -56.2% | -37.2% | -37.8% | -7.8% | -4.3% | -0.1% | 6.4% | -35.3% | -36.3% | -35.6% | -65.9% | -57.0% | -68.5% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -82 | -49 | -47 | 21 | 42 | -50 | -5.3 | 49 | -24 | 5.0 | 97 | 73 | 15 | 2.9 | -14 | 180 | 95 | -161 | 149 | 80 | 50 | -5.4 | -98 | -47 | -57 | 166 | 214 | 157 | 397 | 373 | 217 | 109 | 168 | 141 | 185 | -178 | -65 | -50 | -76 | -46 | |
| – | – | – | – | – | – | – | – | – | – | – | – | 2.2 | 0.0 | -0.1 | 0.9 | 0.5 | -1.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 17.1% | 10.8% | 34.4% | 18.7% | 29.6% | 18.8% | -1.4% | 33.5% | 8.8% | -38.8% | -20.7% | -1.7% | 17.1% | 25.7% | 33.7% | 28.2% | 31.8% | 33.4% | 18.4% | 21.1% | 17.6% | 14.4% | 2.1% | -4.1% | -17.6% | -28.6% | -48.8% | -37.2% | -22.9% | -30.7% | -10.7% | -12.5% | -17.4% | -29.4% | -49.4% | 27.3% | 17.0% | 23.6% | 29.6% | 31.8% | |
| 2.4 | 3.9 | 1.0 | 2.9 | 3.2 | 2.5 | – | 2.8 | 6.2 | – | – | – | 3.2 | 1.7 | 1.1 | 1.9 | 1.5 | 1.4 | 3.2 | 2.6 | 3.1 | 4.2 | 18.1 | – | – | – | – | – | – | – | – | – | – | – | – | 0.3 | 0.4 | 0.6 | 0.5 | 0.6 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -2.01 | -2.87 | -2.81 | -2.38 | -4.90 | -4.08 | -3.45 | -3.06 | -2.89 | -3.07 | -2.68 | -1.62 | -0.15 | 1.15 | 1.95 | 2.04 | 1.85 | 1.51 | -1.05 | -2.19 | -2.93 | -3.74 | -2.72 | -2.97 | -3.58 | -3.74 | -3.42 | -3.03 | -2.22 | -2.13 | -0.47 | -0.26 | 0.00 | 0.25 | -1.13 | -1.37 | -1.58 | -1.41 | -1.11 | -0.85 | |
| 3.87 | 4.29 | 3.65 | 3.22 | 0.07 | 0.08 | 0.07 | 0.05 | 0.02 | 0.00 | 0.54 | 1.65 | 2.96 | 4.54 | 5.85 | 5.50 | 5.59 | 5.42 | 6.08 | 5.22 | 4.60 | 4.25 | 3.93 | 3.56 | 3.07 | 2.71 | 2.31 | 2.08 | 2.16 | 2.31 | 1.81 | 2.03 | 1.99 | 1.67 | 1.70 | 1.23 | 0.72 | 0.35 | 0.34 | 0.33 | |
| 0.64 | 0.44 | 1.60 | 0.63 | 1.04 | 0.52 | -0.03 | 0.99 | 0.18 | -0.57 | -0.56 | -0.05 | 0.71 | 1.34 | 2.11 | 2.41 | 2.92 | 3.20 | 1.75 | 2.07 | 1.65 | 1.27 | 0.16 | -0.29 | -1.25 | -1.76 | -2.48 | -2.00 | -1.37 | -1.73 | -0.65 | -0.73 | -0.76 | -1.14 | -1.58 | 1.03 | 0.76 | 0.51 | 0.58 | 0.39 | |
| -3.19 | -5.84 | -5.25 | -5.54 | -4.91 | -3.51 | -2.72 | -2.23 | -2.10 | -2.35 | -2.66 | -1.86 | -0.49 | 0.34 | 1.28 | 1.59 | 1.51 | 1.67 | 1.87 | 1.03 | 0.59 | -0.50 | -1.22 | -1.87 | -2.52 | -3.12 | -3.25 | -2.81 | -2.68 | -1.57 | -1.22 | -0.47 | -0.54 | -0.18 | 0.00 | -0.91 | -0.78 | -1.15 | -1.25 | -1.58 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.